Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 2567

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 1
Chunk 2567
---
SEC”). Our SEC filings are available to the public through the “Investors” portion of our website as soon
as practicable after we have electronically filed such material with, or furnished it to, the SEC. In addition, the SEC maintains a website
that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC
at www.sec.gov.

Our
internet address is www.oceanbiomedical.com. The information on our website is not, and shall not be deemed to be, part of this Annual
Report on Form 10-K or incorporated into any other filings we make with the SEC, except as shall be expressly set forth by specific reference
in any such filings. All website addresses in this report are intended to be inactive textual references only.

ITEM
1A. RISK FACTORS.

In
the course of conducting our business operations, Ocean Biomedical is exposed to a variety of risks. Any of the risk factors we describe
below have affected or could materially adversely affect our business, financial condition and results of operations. The market price
of shares of our common stock could decline, possibly significantly or permanently, if one or more of these risks and uncertainties occurs.
Certain statements in this Item 1A are forward- looking statements. See “Cautionary Note Regarding Forward-Looking Statements.”

The
risk factors below reflect our business after the Closing of the Business Combination. Unless otherwise noted or the context otherwise
requires, the disclosures in this Item 1A refer to Ocean Biomedical, Inc. and its subsidiaries following the consummation of the Business
Combination.

67

The
risks discussed below are not exhaustive and are based on certain assumptions made by us. We may face additional risks and uncertainties
that are not presently known to us or that we currently deem immaterial, which may also impair our business, financial condition or results
of operations. The following discussion should be read in conjunction with our financial statements and the notes thereto.

Risk
Factors

Risks
Related to Our Common Stock

We
have incurred significant net losses since inception and we are expected to continue to incur significant net losses for the foreseeable
future.

We
have incurred significant net losses since our inception and have financed our operations principally through personal payments made
by our executive chairman and founder and through financings with an institutional investor. We anticipate that we will continue to incur
significant research and development and other expenses related to our ongoing operations, and do not expect to generate income